Gan & Lee Pharmaceuticals. (SHA:603087)
65.97
+0.01 (0.02%)
Apr 16, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 39.27 billion as of April 16, 2026. Its market cap has increased by 44.34% in one year.
Market Cap
39.27B
Enterprise Value
36.10B
Revenue
3.85B
Ranking
n/a
PE Ratio
41.92
Stock Price
65.97
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 39.27B, an increase of 7.36%. That is a compound annual growth rate of 1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 39.26B | -3.10% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intco Medical Technology | 36.15B |
| Andon Health | 36.08B |
| Imeik Technology Development | 34.31B |
| Zhende Medical | 22.38B |
| iRay Group | 22.02B |
| Winner Medical | 19.04B |
| Shenyang Xingqi Pharmaceutical | 16.71B |
| Micro-Tech (Nanjing) Co.,Ltd | 14.96B |